Xeris Pharmaceuticals, Inc.

We sat down with Jennifer Jacobs, MS, BSN, RN (retired), to discuss management and treatment for severe hypoglycemia (very low blood sugar) in schools and how she's had an impact on undesignated glucagon legislation to enhance student safety. This conversation was sponsored by Xeris Pharmaceuticals, Inc. ✏️ Want to learn more about making an impact in your own school? 📺 Watch here:

BIG smiles at our recent PPP Thought Leader Summit! The two-day event brought together Periodic Paralysis patient advocacy organizations, patient engagers, and caregivers from across the country, hosted by Xeris Pharmaceuticals® at our headquarters in Chicago, IL. The summit fostered deep connections and identified ways of collaborating with one another. The conversations about education, awareness, and unity developed valuable insights and future planning for the Periodic Paralysis community. To the attendees: Cienna, Jared, Linda, Ralph, Janine, Kirsten, Paul, Vivienne, Leslie, Dennis- Thank you! We greatly appreciate your time and contributions during the PPP Thought Leader Summit! We value your dedication and leadership. Your leadership helps provide a voice for those who may feel alone living with a rare disease. We enjoyed spending time with each of you and look forward to continued collaboration. #PPP #PeriodicParalysis #RareDisease #ThoughtLeader #Summit

Did you know that this year's summer interns are from five states? - Illinois, Michigan, New Jersey, Texas, and California! Last Thursday, we celebrated #NationalInternDay with our awesome summer interns! It's a privilege to host these 12 individuals who together represent 10 universities across the country. We commend them for their enthusiasm and dedication to growing as young professionals. #XerisPharma #Xeris #SummerInternship #Interns #Pharma

Catch the latest news on diabetes treatments and advancements this Wednesday, July 31 at 7pm ET/4pm PT! Taking Control Of Your Diabetes (TCOYD) and The diaTribe Foundation are providing a free rebroadcast of the 18th Annual Diabetes Forum that took place at #ADA2024. Tune in to hear updates from experts and leaders in the diabetes space. Xeris is a proud sponsor of this forum and is excited to share the learnings with those who didn't have the opportunity to be at ADA in June. To view, simply go to this https://lnkd.in/gb8b6bAM on July 31st.

Every one of us plays a role to stop the harmful misinformation against people with type 2 diabetes, including people with type 1 diabetes. By using thoughtful, inclusive language and sharing the stories of people living with type 2 diabetes—including the depression, anxiety, and burnout caused by diabetes misinformation and blame—we’ll emphasize how everyone can help battle the harm.

Happy Independence Day to all! Today, we celebrate the freedom, unity, and opportunities that define our nation. This paves the way for a diverse culture of excellence and advancement that allows us to better serve Americans living with diabetes and rare diseases. We hope you have a fun-filled day of fireworks and festivities with your loved ones! Whether you choose to relax or be adventurous this holiday, remember to stay safe. #4thofJuly #July4th #IndependenceDay #Pharma #Diabetes #RareDisease

Welcome, Xeris Intern Class of 2024! In early June, our exceptional summer interns started their journey with us. These talented new team members have already made strides embracing innovation and learning more about the world of healthcare. We look forward to their contributions as part of the cross-functional team providing a hands-on approach to the pharmaceutical industry. Collectively, we can further improve patients’ lives. #XerisPharma #Xeris #SummerInternship #Interns #Pharma

Today is #Juneteenth (June 19), a national holiday that commemorates the day that the last enslaved Black Americans were set free in 1865 in Galveston, Texas. We hope all Xeris employees will take time today to reflect on our history, to celebrate how far we’ve come, and to focus on creating a better future.

Xeris Pharmaceuticals® Medical Affairs is excited to share a clinical update with an upcoming Poster Presentation at #ENDO2024. Come and view our Poster (bit.ly/SAT-085) on June 1, 2024, Effects of Levoketoconazole on 24-hour Mean UFC (mUFC) in the SONICS Study: Relation to Baseline mUFC in Adults with Cushing’s Syndrome: a Post-hoc Analysis.

Those who live with diabetes can face unique mental health challenges. The day-to-day management — blood sugar monitoring, medication administration, meal planning and doctor’s appointments — can be overwhelming. For #MentalHealthAwarenessMonth, we’re sharing 6 affirmations for people who live with diabetes. These affirmations can help reset your mindset and shift your perspective toward a more positive outlook. 1. I will not let my diagnosis define me. 2. I'm proud of myself for staying strong. 3. I have the right tools in my diabetes toolkit. 4. I show kindness to myself and others. 5. I feel secure and surrounded by support. 6. I let go of shame and guilt easily. Remember, mental well-being is just as important as physical health. If any of these affirmations resonate with you, tell us why in the comments. #MentalHealthMatters #MentalHealthAwareness #DiabetesCommunity What is GVOKE? GVOKE is a prescription medicine used to treat very low blood sugar (severe hypoglycemia) in people with diabetes ages 2 years and above. It is not known if GVOKE is safe and effective in children under 2 years of age. Do not use GVOKE if: you have a tumor in the gland on top of your kidneys (adrenal gland) called a pheochromocytoma, as it may cause a substantial increase in blood pressure; you have a tumor in your pancreas called an insulinoma, as it may cause low blood sugar; or if you are allergic to glucagon or any inactive ingredient in GVOKE. GVOKE may cause other serious side effects, such as serious skin rash -- in certain people with a tumor in their pancreas called a glucagonoma; Serious allergic reactions -- Call your doctor or get medical help right away if you have a serious allergic reaction including rash, difficulty breathing, low blood pressure. See Important Safety Information: https://lnkd.in/gA79wrqT See Full Prescribing Information: https://bit.ly/3baHqAO US-SM-GVK-24-00044v1